Carole Ben-Maimon

Dr. Carole S.
Ben-Maimon, MD, is a Chief Executive Officer & Director at Larimar Therapeutics, Inc., an Independent Director at VJGJ, Inc., a President, Chief Executive Officer & Director at Bionpharma, Inc. and a President, Chief Executive Officer & Director at Chondrial Therapeutics Holdings LLC.
She is on the Board of Directors at Larimar Therapeutics, Inc., VJGJ, Inc., Bionpharma, Inc., Chondrial Therapeutics Holdings LLC and Jefferson Health Corp.
Dr. Ben-Maimon was previously employed as a President, Chief Executive Officer & Director by Chondrial Therapeutics, Inc., a President-Generic Products by Impax Laboratories, Inc., a President by Global Pharmaceuticals Cos LLC, a Secretary & Senior VP-Corporate Strategy by Propst Distribution, Inc., a President, Chief Executive Officer & Director by Alita Pharmaceuticals, Inc., a President & Director by Barr Pharmaceuticals, Inc., a President & Chief Operating Officer by TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D INC, a Chairman by Generic Pharmaceutical Association, a Senior Vice President-Science & Public Policy by Teva Pharmaceuticals USA, Inc., and a Vice President-Medical & Regulatory Affairs by Lemmon Co. She received her undergraduate degree from Thomas Jefferson University, an undergraduate degree from the University of Pennsylvania and a doctorate degree from Sidney Kimmel Medical College.